在线计算工具的开发和试点测试,用于预测性结肠炎复发风险
Ali Reza Safarpour1, Seyed Alireza Taghavi1, Sara Shojaei-Zarghani1
1Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Middle East journal of digestive diseases
|November 29, 2023
概括
一个在线工具准确地预测了性结肠炎 (UC) 复发风险. 这有助于临床医生和患者识别高危人群,及时进行预防性治疗,减少UC复发和并发症.
科学领域:
- 胃肠病学 胃肠病学
- 临床信息学 临床信息学
- 预测分析是一种预测分析.
背景情况:
- 性结肠炎 (UC) 是一种慢性胃肠道疾病,其特点是不可预测的复发.
- 早期识别患有UC复发高风险的患者对于及时实施预防策略至关重要.
- 预防性治疗可以减轻UC复发和相关严重并发症的风险.
研究的目的:
- 设计和试点测试一种在线计算工具,用于预测性结肠炎患者的复发风险.
- 为临床医生和患者提供一个用户友好的平台,以评估UC复发概率.
- 为了验证在线工具对手工计算的准确性.
主要方法:
- 基于预先建立的UC复发风险预测方程的双语在线网站的开发.
- 利用了之前一项前性研究的数据,该研究涉及157名UC患者处于缓解状态.
- 通过将其计算的风险得分与手动计算的结果对280名UC患者进行比较,验证了在线工具.
主要成果:
- 开发的在线工具 (http://www.ucrelapserisk.com) 证明了对UC患者的复发风险的准确预测.
- 在线和手动计算的UC风险得分和复发概率之间没有发现显著差异.
- 在280名患者中,88名患者被确定为在接下来的一年内复发的高风险患者.
结论:
- 在线UC复发风险预测工具准确且易于患者和医疗保健提供者使用.
- 该工具有助于为性结肠炎管理中的预防性干预措施做出明智的决策.
- 这种工具的可用性可以通过启用主动护理来潜在地改善患者的结果.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
335
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
335
Inflammatory Bowel Disease I: Ulcerative Colitis
190
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
190
Drugs for Treatment of Ulcerative Colitis in IBD
145
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
145


